First Bank & Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$502K Buy
6,415
+82
+1% +$6.41K 0.09% 140
2025
Q1
$459K Buy
6,333
+219
+4% +$15.9K 0.09% 143
2024
Q4
$453K Sell
6,114
-5,977
-49% -$442K 0.09% 145
2024
Q3
$798K Sell
12,091
-9,845
-45% -$650K 0.15% 100
2024
Q2
$2.03M Buy
21,936
+956
+5% +$88.3K 0.41% 56
2024
Q1
$2M Buy
20,980
+490
+2% +$46.8K 0.41% 57
2023
Q4
$1.56M Sell
20,490
-3,108
-13% -$237K 0.38% 68
2023
Q3
$1.63M Sell
23,598
-55
-0.2% -$3.81K 0.43% 58
2023
Q2
$2.23M Buy
23,653
+1,288
+6% +$121K 0.57% 43
2023
Q1
$1.85M Buy
22,365
+3,750
+20% +$310K 0.49% 45
2022
Q4
$1.39M Sell
18,615
-3,481
-16% -$260K 0.39% 63
2022
Q3
$1.83M Buy
22,096
+2,200
+11% +$182K 0.67% 37
2022
Q2
$1.89M Buy
19,896
+3,711
+23% +$353K 0.62% 39
2022
Q1
$1.91M Buy
16,185
+1,820
+13% +$214K 0.59% 40
2021
Q4
$1.86M Buy
14,365
+280
+2% +$36.3K 0.78% 33
2021
Q3
$1.59M Buy
14,085
+24
+0.2% +$2.72K 0.73% 37
2021
Q2
$1.46M Sell
14,061
-259
-2% -$26.8K 0.7% 41
2021
Q1
$1.2M Buy
14,320
+4,251
+42% +$356K 0.6% 47
2020
Q4
$919K Sell
10,069
-5,205
-34% -$475K 0.58% 51
2020
Q3
$1.22M Sell
15,274
-6,293
-29% -$502K 0.81% 39
2020
Q2
$1.49M Buy
21,567
+8,133
+61% +$562K 1.12% 29
2020
Q1
$845K Buy
13,434
+834
+7% +$52.5K 0.76% 39
2019
Q4
$980K Sell
12,600
-1,200
-9% -$93.3K 0.71% 43
2019
Q3
$1.01M Buy
13,800
+456
+3% +$33.4K 0.76% 41
2019
Q2
$822K Buy
13,344
+204
+2% +$12.6K 0.66% 49
2019
Q1
$838K Sell
13,140
-2,190
-14% -$140K 0.65% 54
2018
Q4
$783K Buy
15,330
+474
+3% +$24.2K 0.66% 50
2018
Q3
$714K Hold
14,856
0.54% 66
2018
Q2
$721K Buy
14,856
+1,659
+13% +$80.5K 0.55% 62
2018
Q1
$614K Sell
13,197
-30
-0.2% -$1.4K 0.49% 64
2017
Q4
$497K Sell
13,227
-231
-2% -$8.68K 0.39% 74
2017
Q3
$490K Buy
13,458
+141
+1% +$5.13K 0.4% 71
2017
Q2
$525K Buy
13,317
+228
+2% +$8.99K 0.44% 68
2017
Q1
$410K Buy
13,089
+10,599
+426% +$332K 0.35% 76
2016
Q4
$78K Buy
+2,490
New +$78K 0.07% 182